Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Sponsor: Proteocyte Diagnostics Inc.
Summary
The purpose of this observational study is to evaluate the utility of the S100A7 immunohistochemistry signature-based assessment - STRATICYTE - in determining the risk of progression to cancer of clinically suspicious oral lesions.
Official title: A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE
Key Details
Gender
All
Age Range
15 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2015-03-12
Completion Date
2026-12-31
Last Updated
2024-11-07
Healthy Volunteers
No
Conditions
Interventions
Standard of Care Histopathology
Assessment for mild, moderate, or severe dysplasia, and risk of progression to oral cancer
STRATICYTE Assessment
Assessment for risk of progression to oral cancer
Locations (3)
Kingsway Oral & Maxillofacial Surgery
Edmonton, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
Western University
London, Ontario, Canada